Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences. Posted 10/25/2014 This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.
From the category archives: